Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Crux Biomedical Vena Cava Filter Study - United States

ClinicalTrials.gov ID: NCT01120509

Public ClinicalTrials.gov record NCT01120509. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter System 2

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if the Crux Vena Cava Filter System is safe and effective in preventing pulmonary embolism.

Study identification

NCT ID
NCT01120509
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Crux Biomedical
Industry
Enrollment
88 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2010
Primary completion
May 31, 2011
Completion
Dec 31, 2011
Last update posted
Jun 29, 2014

2010 – 2012

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
St. Joseph's Hospital Orange California 92868
University of California at Irvine Medical Center Orange California 92868
Univeristy of California at Davis Medical Center Sacramento California 95817
Christiana Care Newark Delaware
University of Florida Medical Center Gainesville Florida 32610
Atlanta Medical Center Atlanta Georgia 30312
University Hospital Augusta Georgia 30901
University of Chicago Medical Center Chicago Illinois 60637
St. Francis Hospital Peoria Illinois 61637
Anne Arundel Medical Center Annapolis Maryland 21401
Albany Medical Center Albany New York 12208
Upstate Medical Center Syracuse New York 13210
University of North Carolina Medical Center Chapel Hill North Carolina 27599
Jobst Vascular Institute Toledo Ohio 43606
Hershey Medical Center Hershey Pennsylvania 17033
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
University of Virginia Medical Center Charlottesville Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01120509, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 29, 2014 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01120509 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →